{
    "Trade/Device Name(s)": [
        "COBAS INTEGRA Ceruloplasmin"
    ],
    "Submitter Information": "Roche Diagnostics",
    "510(k) Number": "K062114",
    "Predicate Device Reference 510(k) Number(s)": [
        "K812486"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "CHN"
    ],
    "Summary Letter Date": "January 10, 2007",
    "Summary Letter Received Date": "January 11, 2007",
    "Submission Date": "July 17, 2006",
    "Regulation Number(s)": [
        "21 CFR 866.5210"
    ],
    "Regulation Name(s)": [
        "Ceruloplasmin Immunological Test System"
    ],
    "Analyte Class(es)": [
        "chemistry",
        "immunology"
    ],
    "Analyte(s)": [
        "Ceruloplasmin"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "COBAS INTEGRA Systems",
        "Roche/Hitachi family of analyzers",
        "cobas c6000 series"
    ],
    "Method(s)/Technology(ies)": [
        "Immunoturbidimetric assay",
        "Turbidimetry"
    ],
    "Methodologies": [],
    "Submission Type(s)": [
        "Reagent",
        "Cassette"
    ],
    "Document Summary": "FDA 510(k) summary for COBAS INTEGRA Ceruloplasmin immunoturbidimetric reagent for quantitative determination of ceruloplasmin in serum and plasma",
    "Indications for Use Summary": "In vitro diagnostic test for the quantitative immunological determination of ceruloplasmin in human serum and plasma on COBAS INTEGRA and Roche/Hitachi cobas c systems to aid in the diagnosis of copper metabolism disorders",
    "fda_folder": "Immunology"
}